Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Meyn

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|February 3, 2006
Risk factors for cervicitis among women with bacterial vaginosisJeanne M Marrazzo, Harold C Wiesenfeld, Pamela J Murray, et al.
Acta Biomaterialia|October 3, 2024
Vaginal host response to polycarbonate urethane, an alternative material for the repair of pelvic organ prolapseKatrina Knight, Sophya Breedlove, Temitope Obisesan, et al.
Biomaterials|February 17, 2025
Profiling of the macrophage response to polypropylene mesh burden in vivoMarrisa A Therriault, Srividya Kottapalli, Amanda Artsen, et al.
Obstetrics and Gynecology|August 9, 2016
Self-Administered Lidocaine Gel for Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled TrialRachel B Rapkin, Sharon L Achilles, E Bimla Schwarz, et al.
Sexually Transmitted Diseases|May 12, 2026
Randomized Study of Usual Care vs Xpert® Xpress MVP at the Point of Care for Accurate Diagnosis and Appropriate Treatment of Vaginal InfectionsSharon L Hillier, Ingrid Macio, Rachel Gallagher, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2024
Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testingLaura J Else, Laura Dickinson, Stacey Edick, et al.
Plos One|January 23, 2026
Pharmacokinetics of Dolutegravir, nucleoside analogues, and intracellular metabolites using plasma separation cards: A comparative analysis with traditional sampling methods in healthy volunteersBeth Thompson, Laura J Else, Laura Dickinson, et al.
ACS Infectious Diseases|September 6, 2018
Vaginal Product Formulation Alters the Innate Antiviral Activity and Glycome of Cervicovaginal Fluids with Implications for Viral SusceptibilitySujeethraj Koppolu, Linlin Wang, Ayushi Mathur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2018
A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS IIISharon L Hillier, Patricia Ferrieri, Morven S Edwards, et al.
Scientific Reports|May 10, 2023
A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4<sup>+</sup> cell distribution in the human rectal mucosaMathias Franzén Boger, Nora Benhach, Tyra Hasselrot, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|February 3, 2006
Risk factors for cervicitis among women with bacterial vaginosisJeanne M Marrazzo, Harold C Wiesenfeld, Pamela J Murray, et al.
Acta Biomaterialia|October 3, 2024
Vaginal host response to polycarbonate urethane, an alternative material for the repair of pelvic organ prolapseKatrina Knight, Sophya Breedlove, Temitope Obisesan, et al.
Biomaterials|February 17, 2025
Profiling of the macrophage response to polypropylene mesh burden in vivoMarrisa A Therriault, Srividya Kottapalli, Amanda Artsen, et al.
Obstetrics and Gynecology|August 9, 2016
Self-Administered Lidocaine Gel for Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled TrialRachel B Rapkin, Sharon L Achilles, E Bimla Schwarz, et al.
Sexually Transmitted Diseases|May 12, 2026
Randomized Study of Usual Care vs Xpert® Xpress MVP at the Point of Care for Accurate Diagnosis and Appropriate Treatment of Vaginal InfectionsSharon L Hillier, Ingrid Macio, Rachel Gallagher, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2024
Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testingLaura J Else, Laura Dickinson, Stacey Edick, et al.
Plos One|January 23, 2026
Pharmacokinetics of Dolutegravir, nucleoside analogues, and intracellular metabolites using plasma separation cards: A comparative analysis with traditional sampling methods in healthy volunteersBeth Thompson, Laura J Else, Laura Dickinson, et al.
ACS Infectious Diseases|September 6, 2018
Vaginal Product Formulation Alters the Innate Antiviral Activity and Glycome of Cervicovaginal Fluids with Implications for Viral SusceptibilitySujeethraj Koppolu, Linlin Wang, Ayushi Mathur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2018
A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS IIISharon L Hillier, Patricia Ferrieri, Morven S Edwards, et al.
Scientific Reports|May 10, 2023
A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4<sup>+</sup> cell distribution in the human rectal mucosaMathias Franzén Boger, Nora Benhach, Tyra Hasselrot, et al.
Pageof 5